Handelsbanken Fonder’s Structure Therapeutics GPCR Stock Holding History

Handelsbanken Fonder’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	+19,400	New	+$858K	﹤0.01%	1123
2025 Q4	–	Sell	-168,000	Closed	-$4.7M	–	1518
2025 Q3	$4.7M	Sell	168,000 -212,000	-56%	-$4.22M	0.01%	488
2025 Q2	$7.88M	Hold	380,000	–	–	0.03%	379
2025 Q1	$6.58M	Buy	380,000 +215,000	+130%	+$5.27M	0.03%	392
2024 Q4	$4.47M	Buy	+165,000	New	+$5.85M	0.02%	452

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Handelsbanken Fonder's GPCR Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 19,400 shares worth $1.04M. The stake represents ﹤0.01% of the portfolio and ranks #1123 among its holdings. This is a return to the name: Handelsbanken Fonder previously reported a position in GPCR as recently as Q3 2025.

Handelsbanken Fonder first reported a position in GPCR in Q4 2024 and has held it in 5 quarters since. The position peaked at $7.88M in Q2 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Handelsbanken Fonder held 19,400 shares of Structure Therapeutics worth $1.04M as of Q2 2026.
Structure Therapeutics was a new Handelsbanken Fonder position in Q2 2026.
Structure Therapeutics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1123 holding.
Handelsbanken Fonder first reported a position in Structure Therapeutics in Q4 2024 and has held it in 5 quarters since.
Handelsbanken Fonder's Structure Therapeutics position peaked at $7.88M in Q2 2025.
192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.